Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|10|2|77-90

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.10, Iss.2, 2010-04, pp. : 77-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2113-2116

Bentham Science Publishers

Access to resources Recommend Favorite

Life or Death of T Cells with Antigen-Specific Receptors - Using T Cells for Cancer Adoptive Immunotherapy / Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 253-255

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

By  

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 424-429

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to Improve the Clinical Performance of Chimeric Antigen Receptor-Modified T Cells for Cancer

By  

Current Gene Therapy, Vol. 13, Iss. 1, 2013-02 ,pp. : 65-70

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Approaches for Antigen-Selective Cell Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 4, 2001-11 ,pp. : 385-397

Bentham Science Publishers

Access to resources Recommend Favorite